Newron Pharmaceuticals S.p.A.

SWX:NWRN Stock Report

Market Cap: CHF 141.7m

Newron Pharmaceuticals Dividends and Buybacks

Dividend criteria checks 0/6

Newron Pharmaceuticals does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-5.7%

Buyback Yield

Total Shareholder Yield-5.7%
Future Dividend Yield0%
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Newron Pharmaceuticals S.p.A.'s (VTX:NWRN) Price In Tune With Revenues

Sep 03
Newron Pharmaceuticals S.p.A.'s (VTX:NWRN) Price In Tune With Revenues

Here's Why We Think Newron Pharmaceuticals S.p.A.'s (VTX:NWRN) CEO Compensation Looks Fair for the time being

Apr 11
Here's Why We Think Newron Pharmaceuticals S.p.A.'s (VTX:NWRN) CEO Compensation Looks Fair for the time being

We Think Newron Pharmaceuticals (VTX:NWRN) Has A Fair Chunk Of Debt

Nov 06
We Think Newron Pharmaceuticals (VTX:NWRN) Has A Fair Chunk Of Debt

Shareholders May Be Wary Of Increasing Newron Pharmaceuticals S.p.A.'s (VTX:NWRN) CEO Compensation Package

Apr 06
Shareholders May Be Wary Of Increasing Newron Pharmaceuticals S.p.A.'s (VTX:NWRN) CEO Compensation Package

Newron Pharmaceuticals (VTX:NWRN) Has Debt But No Earnings; Should You Worry?

Apr 01
Newron Pharmaceuticals (VTX:NWRN) Has Debt But No Earnings; Should You Worry?

A Look At Newron Pharmaceuticals' (VTX:NWRN) Share Price Returns

Feb 25
A Look At Newron Pharmaceuticals' (VTX:NWRN) Share Price Returns

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if NWRN's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NWRN's dividend payments have been increasing.


Dividend Yield vs Market

Newron Pharmaceuticals Dividend Yield vs Market
How does NWRN dividend yield compare to the market?
SegmentDividend Yield
Company (NWRN)n/a
Market Bottom 25% (CH)2.0%
Market Top 25% (CH)4.4%
Industry Average (Pharmaceuticals)2.6%
Analyst forecast (NWRN) (up to 3 years)0%

Notable Dividend: Unable to evaluate NWRN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NWRN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate NWRN's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as NWRN has not reported any payouts.


Discover strong dividend paying companies